|
Name |
D-Fructose, 1,3,6-trideoxy-3,6-epithio-
|
Molecular Formula | C6H10O3S | |
IUPAC Name* |
1-(3,4-dihydroxythiolan-2-yl)ethanone
|
|
SMILES |
CC(=O)C1C(C(CS1)O)O
|
|
InChI |
InChI=1S/C6H10O3S/c1-3(7)6-5(9)4(8)2-10-6/h4-6,8-9H,2H2,1H3
|
|
InChIKey |
BLRLPKUJYRPMPS-UHFFFAOYSA-N
|
|
Synonyms |
3,6-Anhydro-1-deoxy-3-thiohex-2-ulose #; D-Fructose, 1,3,6-trideoxy-3,6-epithio-
|
|
CAS | NA | |
PubChem CID | 545997 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 162.21 | ALogp: | -0.2 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 82.8 | Aromatic Rings: | 1 |
Heavy Atoms: | 10 | QED Weighted: | 0.563 |
Caco-2 Permeability: | -4.96 | MDCK Permeability: | 0.00000767 |
Pgp-inhibitor: | 0.113 | Pgp-substrate: | 0.101 |
Human Intestinal Absorption (HIA): | 0.011 | 20% Bioavailability (F20%): | 0.004 |
30% Bioavailability (F30%): | 0.003 |
Blood-Brain-Barrier Penetration (BBB): | 0.563 | Plasma Protein Binding (PPB): | 22.26% |
Volume Distribution (VD): | 0.962 | Fu: | 74.04% |
CYP1A2-inhibitor: | 0.027 | CYP1A2-substrate: | 0.232 |
CYP2C19-inhibitor: | 0.02 | CYP2C19-substrate: | 0.746 |
CYP2C9-inhibitor: | 0.003 | CYP2C9-substrate: | 0.503 |
CYP2D6-inhibitor: | 0.004 | CYP2D6-substrate: | 0.471 |
CYP3A4-inhibitor: | 0.005 | CYP3A4-substrate: | 0.088 |
Clearance (CL): | 7.11 | Half-life (T1/2): | 0.902 |
hERG Blockers: | 0.034 | Human Hepatotoxicity (H-HT): | 0.24 |
Drug-inuced Liver Injury (DILI): | 0.402 | AMES Toxicity: | 0.025 |
Rat Oral Acute Toxicity: | 0.119 | Maximum Recommended Daily Dose: | 0.015 |
Skin Sensitization: | 0.107 | Carcinogencity: | 0.308 |
Eye Corrosion: | 0.015 | Eye Irritation: | 0.397 |
Respiratory Toxicity: | 0.035 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002061 | 0.304 | D05ZYM | 0.250 | ||||
ENC001067 | 0.250 | D07HZY | 0.238 | ||||
ENC003055 | 0.250 | D0MU9L | 0.222 | ||||
ENC001214 | 0.250 | D0Z4EI | 0.222 | ||||
ENC001221 | 0.222 | D04CRL | 0.214 | ||||
ENC000411 | 0.222 | D0S7DV | 0.200 | ||||
ENC001284 | 0.222 | D0HR8Z | 0.200 | ||||
ENC001888 | 0.222 | D0I8RR | 0.197 | ||||
ENC003046 | 0.217 | D0R9BG | 0.194 | ||||
ENC005640 | 0.216 | D0D0ZD | 0.189 |